Search
Liranaftate
go.drugbank.com/drugs/DB19985ExperimentalLiranaftate is a small molecule drug. Liranaftate has a monoisotopic molecular weight of 328.12 Da.
Categories: Antifungals for Topical Use, Antifungals for Dermatological UseAzelnidipine
go.drugbank.com/drugs/DB09230InvestigationalIt is currently being studied for post-ischemic stroke management [L1380].
Rocapuldencel-T
go.drugbank.com/drugs/DB17588InvestigationalRocapuldencel-T is an autologous dendritic cell immunotherapy that was investigated in NCT02662634 (A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer
AVXS-301
go.drugbank.com/drugs/DB17943ExperimentalIt is being investigated for the treatment of Amyotrophic Lateral Sclerosis (ALS).[L47077]
Modimelanotide
go.drugbank.com/drugs/DB15314InvestigationalModimelanotide is under investigation in clinical trial NCT01897519 (A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing
Levonadifloxacin
go.drugbank.com/drugs/DB16219InvestigationalLevonadifloxacin is under investigation in clinical trial NCT03405064 (Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)).
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseFlomoxef
go.drugbank.com/drugs/DB11935InvestigationalFlomoxef has been used in trials studying the treatment of Urinary Tract Infection.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseCDX-1135
go.drugbank.com/drugs/DB17607InvestigationalIt was investigated in clinical trials for post-cardiopulmonary bypass syndrome and kidney damage.
AAV-AIPL
go.drugbank.com/drugs/DB17857ExperimentalDeveloped by MeiraGTx, it is being investigated for the treatment of inherited retinal dystrophy due to defects in _AIPL1_ gene.
Fiztasovimab
go.drugbank.com/drugs/DB24033Investigational[A278004, A278005] NPC-21 is under investigation in clinical trial NCT04225923 (A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection).